You have 9 free searches left this month | for more free features.

INC424

Showing 1 - 25 of 519

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Graft-versus-host Disease Trial in Milwaukee (Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil)

Not yet recruiting
  • Graft-versus-host Disease
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Jan 26, 2023

Myelofibrosis Trial in Worldwide (PIM447, Ruxolitinib, LEE011)

Completed
  • Myelofibrosis
  • VIC, Melbourne, Australia
  • +8 more
Feb 7, 2022

Pancreatic Ductal Adenocarcinoma Trial in Miami (Trametinib, Ruxolitinib, Retifanlimab)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Miami, Florida
    University of Miami
Jun 27, 2022

Contraception Trial in Savannah (LPRI424 (dienogest/ethinylestradiol))

Active, not recruiting
  • Contraception
  • LPRI424 (dienogest/ethinylestradiol)
  • Savannah, Georgia
    Fellows Research Alliance, Inc.
Sep 14, 2022

Myelofibrosis Trial in Worldwide (INC424, BKM120)

Terminated
  • Myelofibrosis
  • Herston, Queensland, Australia
  • +14 more
Dec 16, 2020

Parkinson Disease Trial in United States (CVN424 Low Dose, CVN424 High Dose, Placebo)

Completed
  • Parkinson Disease
  • CVN424 Low Dose
  • +2 more
  • Long Beach, California
  • +20 more
Aug 4, 2022

Myelofibrosis Trial in Worldwide (Ruxolitinib)

Completed
  • Myelofibrosis
  • Winter Park, Florida
  • +17 more
Jan 10, 2022

GVHD Trial in Worldwide (INC424)

Active, not recruiting
  • Graft vs Host Disease
  • INC424
  • Sao Paulo, Brazil
  • +20 more
Oct 26, 2022

Hypercholesterolemia, Atherosclerotic Ischemic Disease Trial in Heidelberg, London (lerodalcibep, Inclisiran)

Enrolling by invitation
  • Hypercholesterolemia
  • Atherosclerotic Ischemic Disease
  • Nantes, Cedex 01, France
  • +6 more
Nov 3, 2022

Primary Myelofibrosis, Thrombocytosis, Essential Thrombocythemia Trial in Worldwide (LDE225, INC424)

Completed
  • Primary Myelofibrosis
  • +9 more
  • Camperdown, New South Wales, Australia
  • +17 more
Apr 3, 2020

Myelofibrosis Trial in Worldwide (Ruxolitinib, Siremadlin, Crizanlizumab)

Suspended
  • Myelofibrosis
  • Adelaide, South Australia, Australia
  • +37 more
Aug 18, 2022

Primary Myelofibrosis (MF), Post-Polycythemia Vera (PV) MF, Post-Essential Thrombocythemia (ET) MF Trial in Worldwide

Completed
  • Primary Myelofibrosis (MF)
  • +2 more
  • Beijing, Beijing, China
  • +25 more
Aug 29, 2019

Polycythemia Vera Trial in Worldwide (Best Available Therapy, Ruxolitinib)

Completed
  • Polycythemia Vera
  • Herston, Queensland, Australia
  • +47 more
Jun 29, 2021

Leukemia Trial in Houston (Ruxolitinib)

Terminated
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 3, 2019

Cytokine Storm (Covid-19) Trial in Worldwide (Ruxolitinib, Placebo)

Completed
  • Cytokine Storm (Covid-19)
  • Fullerton, California
  • +60 more
Oct 7, 2021

Glaucoma, Open-Angle Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Sham Bimatoprost SR, Selective Laser

Completed
  • Glaucoma
  • Open-Angle Ocular Hypertension
  • Bimatoprost SR
  • +3 more
  • Dothan, Alabama
  • +32 more
Feb 22, 2022

Glaucoma, Open-Angle, Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Sham Bimatoprost SR, Selective Laser

Active, not recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Bimatoprost SR
  • +3 more
  • Dothan, Alabama
  • +94 more
Nov 1, 2022

Myeloproliferative Diseases Trial in Houston (Ruxolitinib, Pracinostat, Questionnaire)

Completed
  • Myeloproliferative Diseases
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 10, 2019

Alzheimer, Cognitive Dysfunction, Dementia Trial in Worldwide (JNJ-63733657, Placebo)

Recruiting
  • Alzheimer Disease
  • +2 more
  • Birmingham, Alabama
  • +143 more
Jan 31, 2023

Leukemia Trial in Houston (Ruxolitinib)

Completed
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 11, 2019

Neurotrophic Keratitis Trial (BRM424 Ophthalmic Solution, Vehicle)

Not yet recruiting
  • Neurotrophic Keratitis
  • (no location specified)
Jun 28, 2023

Obesity, Overweight, Type 2 Diabetes Trial in Worldwide (Orforglipron, Placebo)

Not yet recruiting
  • Obesity
  • +2 more
  • Pelham, Alabama
  • +135 more
May 15, 2023

Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Canada,

Terminated
  • Primary Myelofibrosis
  • +2 more
  • Ruxolitinib Pre- Hematopoietic cell transplantation (HCT)
  • Atlanta, Georgia
  • +7 more
Feb 28, 2019

Polycythemia Vera Trial (Ruxolitinib)

Available
  • Polycythemia Vera
  • (no location specified)
Mar 7, 2022